|
Market Closed -
Other stock markets
|
After hours 01:00:00 | |||
| 623.54 USD | -1.31% |
|
618.83 | -0.76% |
| 06-29 | Eli Lilly, Regeneron Among First Companies in FDA PreCheck Pilot Program | MT |
| 06-29 | Lilly, Regeneron selected for US program to review new manufacturing plants faster | RE |
| Market Cap | 63.45B 55.54B 51.27B 47.83B 90.11B 6,000B 91.72B 615B 239B 2,961B 238B 233B 10,314B | P/E 2026 * |
16.1x | P/E 2027 * | 13x |
|---|---|---|---|---|---|
| Enterprise Value | 55.54B 48.62B 44.88B 41.86B 78.87B 5,252B 80.29B 538B 209B 2,591B 209B 204B 9,028B | EV / Sales 2026 * |
3.5x | EV / Sales 2027 * | 3.01x |
| Free-Float |
72.33% | Yield 2026 * |
0.63% | Yield 2027 * | 0.71% |
Last Transcript: Regeneron Pharmaceuticals, Inc.
| 1 day | -1.31% | ||
| 1 week | +0.89% | ||
| 1 month | +1.42% | ||
| 3 months | -19.30% | ||
| 6 months | -19.22% | ||
| Current year | -19.22% |
| 1 week | 619.7 |  | 638.76 |
| 1 month | 591.52 | | 640.82 |
| Current year | 591.52 | | 821.11 |
| 1 year | 529.69 | | 821.11 |
| 3 years | 476.49 | | 1,211.2 |
| 5 years | 476.49 | | 1,211.2 |
| 10 years | 271.37 | | 1,211.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
| President | 66 | 31/12/2000 | |
| Chief Executive Officer | 73 | 07/01/1988 | |
| Director of Finance/CFO | 55 | 04/02/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 73 | 08/06/2023 | |
Michael Brown
BRD | Director/Board Member | 85 | 31/05/1991 |
Joseph Goldstein
BRD | Director/Board Member | 85 | 31/05/1991 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 04-30 | Sell | Director | -100 | 0.0001% | ||
| 03-31 | Sell | Director | 100 | 0.0001% | ||
| 03-01 | Sell | Director | 100 | 0.0001% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.31% | +0.89% | +18.77% | -13.22% | 63.44B | |
| -0.57% | +4.09% | +56.93% | +222.66% | 56.98B | |
| -3.94% | +39.10% | +39.10% | +39.10% | 41.58B | |
| +3.16% | +2.94% | -50.31% | -57.15% | 38.01B | |
| -0.26% | +9.57% | +72.04% | -24.15% | 31.9B | |
| +0.47% | +14.80% | +153.82% | -42.36% | 27.79B | |
| -1.13% | +8.58% | +66.46% | +82.10% | 22.65B | |
| -0.56% | +4.05% | +1.53% | +168.92% | 17.64B | |
| -0.13% | -0.94% | +60.31% | +119.58% | 16.49B | |
| +3.43% | +8.52% | +72.49% | +333.02% | 14.59B | |
| Average | -0.08% | +5.44% | +49.11% | +82.85% | 33.11B | |
| Weighted average by Cap. | -0.43% | +4.64% | +43.21% | +63.50% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 15.88B 13.9B 12.83B 11.97B 22.55B 1,502B 22.96B 154B 59.75B 741B 59.66B 58.33B 2,581B | 17.55B 15.36B 14.18B 13.23B 24.93B 1,660B 25.37B 170B 66.05B 819B 65.95B 64.47B 2,853B |
| Net income | 4.09B 3.58B 3.3B 3.08B 5.81B 387B 5.91B 39.62B 15.38B 191B 15.36B 15.02B 665B | 5.13B 4.49B 4.15B 3.87B 7.29B 485B 7.42B 49.75B 19.32B 240B 19.29B 18.86B 834B |
| Net Debt | -7.91B -6.93B -6.39B -5.96B -11.24B -748B -11.44B -76.69B -29.77B -369B -29.73B -29.07B -1,286B | -10.69B -9.35B -8.63B -8.05B -15.17B -1,010B -15.45B -104B -40.2B -499B -40.14B -39.25B -1,737B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/06/26 | US$623.54 | -1.31% | 820,925 |
| 29/06/26 | US$631.81 | -0.17% | 734,528 |
| 26/06/26 | US$632.90 | +2.06% | 1,213,634 |
| 25/06/26 | US$620.14 | -0.53% | 696,862 |
| 24/06/26 | US$623.43 | +0.87% | 839,934 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- REGN Stock
Select your edition
All financial news and data tailored to specific country editions
